Yantai Zhenghai Biotechnology Co., Ltd.
300653.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.85B
Close$
$29.56
99.7% upside
Current Fair Value
99.7% upsideUndervalued by 99.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.85 Billion |
|---|---|
| Enterprise Value | $2.78 Billion |
| Dividend Yield | $0.28 (1.75%) |
| Earnings per Share | $0.46 |
| Beta | 0.11 |
| Outstanding Shares | 166,224,638 |
Return
| Return on Equity | 7.93% |
|---|---|
| Return on Assets | 7.14% |
| Return on Invested Capital | 7.49% |
Valuation & Multiples
| P/E Ratio | 41.44 |
|---|---|
| PEG | -632.02 |
| Price to Sales | 7.4 |
| Price to Book Ratio | 2.96 |
| Enterprise Value to Revenue | 8.27 |
| Enterprise Value to EBIT | 42.03 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 25, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$78.74 M
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$80.04 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Yantai Zhenghai Biotechnology Co., Ltd.
386 employees
CEO: Kan Song Yantai Zhenghai Biotechnology Co., Ltd., founded in 2003 and based in Yantai, China, specializes in the innovation, manufacturing, and commercialization of regenerative medical materials across China. The company's product offerings incl...